肝硬化患者细菌感染消退后早期再入院的预测因素
研究纳入199例因细菌和/或真菌感染住院后出院的肝硬化患者,随访至少6个月。出院时C反应蛋白(OR=1.91;P=0.022)、住院期间慢加急性肝衰竭(OR=2.48;P=0.008)及入组前30天内住院(OR=1.50;P=0.042)为30天再入院的独立预测因素;年龄、MELD评分、CRP、难治性腹水及糖尿病为6个月死亡的独立预测因素。出院时CRP>10 mg/l者30天再入院率44% vs. 24%(P=0.007),6个月生存率62% vs. 88%(P<0.001)。
要点
- 出院时CRP(OR=1.91)、住院期间慢加急性肝衰竭(OR=2.48)及前30天内住院(OR=1.50)预测30天再入院。
- 出院时CRP>10 mg/l者30天再入院率44% vs. 24%(P=0.007),6个月生存率62% vs. 88%(P<0.001)。
- 年龄、MELD评分、CRP、难治性腹水及糖尿病为6个月死亡的独立预测因素。
核心结论
- CRP是肝硬化患者因细菌和/或真菌感染住院后早期再入院和6个月死亡率的强预测因素。
研究设计与样本
- 研究纳入199例因细菌和/或真菌感染住院后出院的肝硬化患者,随访至少6个月。
主要发现
- 随访期间69例(35%)在出院后30天内再入院。
- 出院时CRP(OR=1.91;P=0.022)、住院期间慢加急性肝衰竭(OR=2.48;P=0.008)及入组前30天内住院(OR=1.50;P=0.042)为再入院的独立预测因素。
- 6个月随访期间47例(23%)死亡。
- 年龄(HR=1.05;P=0.001)、MELD评分(HR=1.13;P<0.001)、CRP(HR=1.85;P=0.001)、难治性腹水(HR=2.22;P=0.007)及糖尿病(HR=2.41;P=0.010)为6个月死亡的独立预测因素。
- 出院时CRP>10 mg/l者较CRP≤10 mg/l者30天再入院概率显著更高(44% vs. 24%;P=0.007),6个月生存概率显著更低(62% vs. 88%;P<0.001)。
临床怎么用
- CRP值可用于抗生素管理及识别需要严格监测程序的脆弱患者。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In patients with cirrhosis, infections represent a frequent trigger for complications, increasing frequency of hospitalizations and mortality rate. This study aimed to identify predictors of early readmission (30 days) and of mid-term mortality (6 months) in patients with liver cirrhosis discharged after a hospitalization for bacterial and/or fungal infection. METHODS: A total of 199 patients with cirrhosis discharged after an admission for a bacterial and/or fungal infection were included in the study and followed up for a least 6 months. RESULTS: During follow-up, 69 patients (35%) were readmitted within 30 days from discharge. C-reactive protein (CRP) value at discharge (odds ratio (OR)=1.91; P=0.022), diagnosis of acute-on-chronic liver failure during the hospital stay (OR=2.48; P=0.008), and the hospitalization in the last 30 days previous to the admission/inclusion in the study (OR=1.50; P=0.042) were found to be independent predictors of readmission. During the 6-month follow-up, 47 patients (23%) died. Age (hazard ratio (HR)=1.05; P=0.001), model of end-stage liver disease (MELD) score (HR=1.13; P<0.001), CRP (HR=1.85; P=0.001), refractory ascites (HR=2.22; P=0.007), and diabetes (HR=2.41; P=0.010) were found to be independent predictors of 6-month mortality. Patients with a CRP >10 mg/l at discharge had a significantly higher probability of being readmitted within 30 days (44% vs. 24%; P=0.007) and a significantly lower probability of 6-month survival (62% vs. 88%; P<0.001) than those with a CRP ≤10 mg/l. CONCLUSIONS: CRP showed to be a strong predictor of early hospital readmission and 6-month mortality in patients with cirrhosis after hospitalization for bacterial and/or fungal infection. CRP values could be used both in the stewardship of antibiotic treatment and to identify fragile patients who deserve a strict surveillance program.
引用
- Piano S, Morando F, Carretta G, et al. Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections. Am J Gastroenterol. 2017. PMID: 28853729. doi:10.1038/ajg.2017.253
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。